Menu

Aditi Khurana

Aditi Khurana

Aditi is an experienced program executive in the Pharma industry specializing in the oncology and neuroscience therapeutic areas. She started her career as a licensed Clinical Cytogenetics & Molecular Biologist working on genetic disorders and currently works as a project management leader in drug development. She has co-authored several publications in the diagnostics space, and presented on the topic of international regulatory frameworks for acceleration of drug approval, real world evidence, and digital health. Aditi got her MBA from UIUC and a Bachelors in Neuroscience from UCLA, and has PMP and RAC certifications.

All blogs by Aditi Khurana

Follow us

AVG Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: info@av.vc

Press inquiries: press@av.vc

603-206-5508

Follow us

Neither Alumni Ventures Group nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made.

Testimonial Policy: Testimonials were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest.

Investor Updates: Private investor portals and dashboards are updated once per quarter.

Alumni Ventures is America’s largest venture firm for individuals by combination of number of investors, investments and capital raised.

(1) Internal Rate of Return (IRR) for AV Funds is net of management fees and incentive allocations applied to amounts distributed to investors, and gross of incentive allocations applicable to unrealized gains on investments held by AV Funds. IRR for AV Funds includes uninvested cash, unrealized investments, and amounts distributed to investors. The IRR shown for the Russell 2000 indices are gross of fees because indices are not managed investments, and it is not possible to invest directly in an index. For additional information see av-funds.com/disclosures. All investment involves risk, including risk of loss. Past performance is not necessarily indicative of future results. For more information on AV Funds’ investment returns, please see here.

© 2024, Alumni Ventures Group. All rights reserved.